A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction [0.03%]
欧洲多国对射血分数降低的心力衰竭中恩格列净成本效益分析
Ali Tafazzoli,Odette S Reifsnider,Leana Bellanca et al.
Ali Tafazzoli et al.
Purpose: This research examined the cost-effectiveness of adding empagliflozin to standard of care (SoC) compared with SoC alone for treatment of heart failure with reduced ejection fraction (HFrEF) from the perspective o...
Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer´s patients: a Finnish nationwide register study [0.03%]
抗痴呆药物的早期使用与阿尔茨海默病患者的健康和社会护理成本较低有关：一项芬兰全国登记研究
Aino Vesikansa,Olli Halminen,Juha Mehtälä et al.
Aino Vesikansa et al.
Objectives: To evaluate the association between health and social care costs and early start of anti-dementia medication in a nationwide cohort of Finnish Alzheimer's disease (AD) patients. ...
Petra Landovská,Martina Karbanová
Petra Landovská
Increasing prevalence of obesity (BMI > 30) is a pressing public health issue in the Czech Republic as well as world-wide, affecting up to 2.1 billion people. Increasing trend in the prevalence of obesity in adults and children generates la...
Public preferences for policies promoting a healthy diet: a discrete choice experiment [0.03%]
促进健康饮食的政策的公众偏好：一项独立选择实验分析
C M Dieteren,I Bonfrer,W B F Brouwer et al.
C M Dieteren et al.
Background: Worldwide obesity rates have nearly tripled over the past five decades. So far, policies to promote a healthier diet have been less intrusive than those to reduce tobacco and alcohol consumption. Not much is k...
Chantelle Murley,Petter Tinghög,Fitsum Sebsibe Teni et al.
Chantelle Murley et al.
Background and objective: Population-based estimates of the socioeconomic burden of multiple sclerosis (MS) are limited, especially regarding primary healthcare. This study aimed to estimate the excess costs of people wit...
EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy [0.03%]
脊髓和球状肌肉萎缩症患者的EQ-5D与SF-6D健康效用分数研究
Richard Huan Xu,Ming Lu,Shuyang Zhang et al.
Richard Huan Xu et al.
Objective: This study assessed patient-reported health-related quality of life (HRQoL) using two generic preference-based measures in Chinese patients with spinal and bulbar muscular atrophy (SBMA) and identified demograp...
Out-of-pocket costs sustained in the last 12 months by cancer patients: an Italian survey-based study on individual expenses between 2017 and 2018 [0.03%]
癌症患者在过去12个月中自付的费用：一项基于2017年至2018年意大利个人支出的研究
Roberto Lillini,Francesco De Lorenzo,Paolo Baili et al.
Roberto Lillini et al.
Purpose: Out of Pocket costs (OOP) sustained by cancer patients also in public NHS contribute to disease-related financial toxicity. Aim of the study was to investigate the amount and the types of OOP sustained by Italian...
Significant healthcare burden and life cost of spinal muscular atrophy: real-world data [0.03%]
脊髓性肌萎缩症的医疗负担和生命成本显著增高：现实世界数据
Sophelia H S Chan,Carlos K H Wong,Tingting Wu et al.
Sophelia H S Chan et al.
Objectives: The aim of this study is to quantify the mortality rate, direct healthcare costs, and cumulative life costs of pediatric patients with spinal muscular atrophy (SMA) type 1, type 2, and type 3 born in Hong Kong...
Livio Garattini,Marco Badinella Martini,Alessandro Nobili
Livio Garattini
Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment [0.03%]
利用离散选择实验建立澳大利亚幼儿口腔健康影响尺度4D(ECOHIS-4D)效用值系统
Ruvini M Hettiarachchi,Peter Arrow,Sameera Senanayake et al.
Ruvini M Hettiarachchi et al.
Purpose: Preference-based quality of life measures (PBMs) are used to generate quality-adjusted life years (QALYs) in economic evaluations. A PBM consists of (1) a health state classification system and (2) a utility valu...